Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Comment by cautiousguyon Oct 23, 2020 10:20pm
372 Views
Post# 31775755

RE:The CEO is a GENIUS everyone needs to watch this ..$6.00soon

RE:The CEO is a GENIUS everyone needs to watch this ..$6.00soonI don't think there is any real question about the potential of Psilocybin or the good doctor to use his medical skills to improve people's lives.  The continuing question(s) is why Champignon -and its board- seems to be so incompetent (or  incapable) in not only getting the paper work completed, so seemingly incompetent (or indifferent) in maintaining a current presence in social media, and not speaking directly with shareholders in regards to the pivoting that has taken place over the past half a year.   

Screw the $6.00 soon and the associated claptrap ... that's just wishful hyperbole.  Nothing will happen until the board gets its act together.

<< Previous
Bullboard Posts
Next >>